MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Factors underlying reduced aerobic capacity in Huntington disease

A. Rao, S. Norris, J. Montes, P. Wasserman, K. Marder (New York, NY, USA)

Meeting: 2019 International Congress

Abstract Number: 42

Keywords: Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features, Chorea (also see specific diagnoses, Huntingtons disease, etc): Pathophysiology, Oxidative stress

Session Information

Date: Monday, September 23, 2019

Session Title: Huntington’s Disease

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: Examine factors underlying aerobic capacity in prodromal and manifest Huntington disease (HD) and matched controls

Background: HD results in motor impairments, weight loss, muscle weakness and wasting. While exercise training may be beneficial, it is important to understand factors underlying aerobic capacity

Method: We examined 10 pHD (mean= 43.2y), 10 mHD (mean = 52.5y), and 8 controls (mean = 46.6y). Aerobic capacity was measured with the cardiopulmonary exercise test (CPET) on a recumbent cycle ergometer. Primary outcomes were oxygen consumption (VO2), heart rate and workload. Body composition was measured using Bioelectrical Impedance Analysis and lean body mass was determined. In vivo muscle oxygen uptake was measured in the vastus lateralis with Near Infra-Red Spectroscopy. Primary outcome was change in deoxyhemoglobin (DMOx)from rest to peak exercise. Disease burden was measured with the CAP score (based on CAG repeat length and age). Motor impairment was measured with the Unified Huntington Disease Rating Scale (UHDRS). Demographic and clinical measures across groups were analyzed with One-way ANOVA. VO2, heart rate and workload were analyzed with factorial ANOVA. Regression analysis was used to examine if lean body mass, motor impairment and muscle deoxygenation were related to aerobic capacity, after adjusting for age.

Results: Age, height, weight, and lean body mass were similar across groups (p>0.05). During the CPET, peak VO2 was lower in prodromal HD (p<0.01) and peak VO2, heart rate and workload were reduced in manifest HD (p<0.05). Differences in VO2 were accentuated in prodromal and manifest HD at exercise intensity ≥ 75%. DMOxwas lower in prodromal and manifest HD (p<0.03) than controls at peak exercise. UHDRS motor score (p=0.006) and DMOx(p=0.008) were predictive of aerobic capacity, after adjusting for age.

Conclusion: Aerobic capacity is reduced in prodromal HD due to lower VO2. In manifest HD, aerobic capacity was reduced due to lower VO2, heart rate and workload. Reduced aerobic capacity in prodromal and manifest HD were accentuated at high exercise intensities. Motor impairments and reduced muscle oxygen uptake were predictive of aerobic capacity. Our results suggest that exercise training at an intensity less than 75% of peak may prevent exacerbation of muscle oxidative deficits in people with HD.

To cite this abstract in AMA style:

A. Rao, S. Norris, J. Montes, P. Wasserman, K. Marder. Factors underlying reduced aerobic capacity in Huntington disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/factors-underlying-reduced-aerobic-capacity-in-huntington-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/factors-underlying-reduced-aerobic-capacity-in-huntington-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley